A few weeks ago, I was helping a healthcare organization build data views that would eventually power operational reporting. The…

GSK has secured FDA expansion of its respiratory syncytial virus vaccine Aleksby for adults aged 18 to 49 who are…

When solving life’s biggest problems, adults often rely on scientific evidence, religious faith, or a combination of both to understand…

Dive into the pivotal clinical trials shaping 2026, from Eli Lilly’s retatrutide for obesity to cancer breakthroughs and AI-driven methodologies. Essential insights for clinical researchers and medical academics.

Pharma trends 2026 bring surging R&D costs, regulatory volatility, and tech disruptions, but AI innovations, decentralized trials, and promising clinical pipelines offer key opportunities for drug developers.